Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Blood transplants may be more harmful than bone marrow transplants in pediatric leukemia patients

03.11.2004


Results differ from adult patients, underscore need for more research



A new study has shown for the first time that transplantation of peripheral blood stem cells (PBSC) from sibling donors may be more harmful than bone marrow in pediatric leukemia patients.

Researchers from the International Bone Marrow Transplant Registry (IBMTR) found that patients undergoing PBSC transplants were more likely to die of transplant-related causes than those who underwent bone marrow transplants. It is estimated that nearly 30% of transplants from sibling donors in pediatric patients now use peripheral blood stem cells. The study and an accompanying editorial will be published November 1 in the Journal of Clinical Oncology (JCO).


"Our data support the use of bone marrow for transplantation in these patients when a matched sibling donor is available," said Mary Eapen, MBBS, MS, Assistant Professor at the Medical College of Wisconsin and lead author of the study. "The higher rates of mortality observed after PBSC transplantation compared to bone marrow transplantation should serve as a cautionary note, and underscore the urgent need for a properly designed clinical trial to define the role, if any, of donor peripheral blood stem cell transplantation in children."

Background

Leukemia is cancer of the bone marrow. Bone marrow transplants involve the collection from the donor of "hematopoietic" stem cells - immature cells found in the bone marrow that mature into red blood cells, white blood cells, and platelets. Doctors have traditionally treated children with leukemia using bone marrow donated from a sibling when available, or from an unrelated volunteer donor. Another approach is peripheral blood stem cell (PBSC) transplantation, in which these stem cells are collected from the donor’s blood, rather than directly from their bone marrow.

In both types of transplantation, the patient’s cancerous bone marrow is destroyed with high doses of chemotherapy or radiation. Then bone marrow or peripheral blood stem cells are given to the patient, which replaces the destroyed marrow.

In adults, peripheral blood collection has become increasingly common in recent years, because it allows donors to avoid the difficulties of bone marrow collection, such as surgery and anesthesia. Since peripheral blood transplantation has been shown to be as safe and effective as bone marrow transplantation in adults, some doctors have begun recommending use of peripheral blood transplants in pediatric patients.

Findings

Eapen and her colleagues compared the outcomes of 143 PBSC and 630 bone marrow transplants in patients with acute leukemia aged 8-20 years who were transplanted between 1995 and 2000. This analysis was performed with data reported to the International Bone Marrow Transplant Registry (IBMTR).

Despite faster recovery of blood counts, more patients who underwent PBSC transplantation died as result of transplant-related complications (26%, compared to 14% of bone marrow transplants) - especially chronic graft-versus-host disease, a potentially serious complication in which the transplanted cells attack the tissues of the recipient. Chronic graft-versus-host disease was significantly higher after PBSC transplants than after bone marrow transplants (33% vs. 19%).

Overall mortality was also higher after PBSC transplants - 57%, versus 44% after bone marrow transplants. The risk of leukemia recurrence after transplantation did not differ. These results persisted after controlling for relevant risk factors that may affect outcomes after transplantation. It is important to note that the current study addresses transplants from donors only, not "autologous" PBSC transplants, in which stem cells are taken from the patient’s own blood. This approach has been proven safe among adults and children, and is widely used.

An accompanying editorial by Donna A. Wall, MD, of the Texas Transplant Institute in San Antonio, underscored the need for a prospective study designed to assess PBSC and bone marrow transplantation in pediatric patients. "This is an unsettling finding, given that nearly 30% of transplants from sibling donors in pediatric patients now use peripheral blood grafts," Dr. Wall said. "It very well may be that peripheral blood stem cells do not offer a benefit over bone marrow in pediatric patients. It is critical that this question be carefully studied by prospectively identifying the patients, diseases, and clinical settings in which clinical benefit is likely to be observed. Until then, patients and families need to be informed about the risks of transplant-related morbidity, including chronic graft-versus-host disease and higher risk of mortality."

Danielle Potuto | EurekAlert!
Further information:
http://www.asco.org

More articles from Studies and Analyses:

nachricht WAKE-UP provides new treatment option for stroke patients | International study led by UKE
17.05.2018 | Universitätsklinikum Hamburg-Eppendorf

nachricht First form of therapy for childhood dementia CLN2 developed
25.04.2018 | Universitätsklinikum Hamburg-Eppendorf

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Powerful IT security for the car of the future – research alliance develops new approaches

The more electronics steer, accelerate and brake cars, the more important it is to protect them against cyber-attacks. That is why 15 partners from industry and academia will work together over the next three years on new approaches to IT security in self-driving cars. The joint project goes by the name Security For Connected, Autonomous Cars (SecForCARs) and has funding of €7.2 million from the German Federal Ministry of Education and Research. Infineon is leading the project.

Vehicles already offer diverse communication interfaces and more and more automated functions, such as distance and lane-keeping assist systems. At the same...

Im Focus: Molecular switch will facilitate the development of pioneering electro-optical devices

A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.

The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...

Im Focus: LZH showcases laser material processing of tomorrow at the LASYS 2018

At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.

At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...

Im Focus: Self-illuminating pixels for a new display generation

There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?

At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

In focus: Climate adapted plants

25.05.2018 | Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

 
Latest News

In focus: Climate adapted plants

25.05.2018 | Event News

Flow probes from the 3D printer

25.05.2018 | Machine Engineering

Less is more? Gene switch for healthy aging found

25.05.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>